Bio-AMD Inc. (fka BIAD)

[BiotechValues]

Just an FYI- I hope to interview management for an update on their MIDS technology next month (March).

There was a lot they couldn't disclose/talk about re: the Sysmex deal in the original article as they are in negotiations (public information in SEC filings)and want to be extremely careful.

But their MIDS technology, (also obtained for pennies on the dollar via bankruptcy), is something they can discuss more openly.

From original report:

"Market research company Market research companyInventya Ltd.is currently preparing a market report on the potential for MIDS. The report will include a survey of key buyers and interviews with target development partners as well as pricing and likely commercialization strategies. “Interviews with target development partners”, among other items in the report, should increase investor awareness and share price appreciation in Bio-AMD as the company’s MIDS technology gains recognition.'

So MIDS market report next month could be another short term catalyst. But for those with a 6-12 month horizon, BIAD is a double, and that's being conservative IMO.

Gary Anderson

MicrocapResearch.com